Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W van Oosten

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|April 26, 2013
PML in a patient treated with dimethyl fumarate from a compounding pharmacyBob W van Oosten, Joep Killestein, Frederik Barkhof, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 15, 2024
[Treatment of multiple sclerosis]Nandi Meijs, Brigit A De Jong, Bob W Van Oosten, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonistB W van Oosten, J Killestein, E M H Mathus-Vliegen, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 16, 2008
[Diabetes and Ramadan]M Ahdi, F Malki, W van Oosten, et al.
Multiple Sclerosis and Related Disorders|November 4, 2019
Patients' expectations of autologous hematopoietic stem cell transplantation as a treatment for MSFloriaan G C M De Kleermaeker, Bernard M J Uitdehaag, Bob W van Oosten
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2007
[Immunomodulatory therapy in multiple sclerosis]B M J Uitdehaag, B Jelles, J Killestein, et al.
Multiple Sclerosis and Related Disorders|October 23, 2017
Neuromyelitis optica spectrum disorder mimicking multiple sclerosisLucas C van Rooij, Mike P Wattjes, Brigit A de Jong, et al.
Journal of Neurology|April 8, 2014
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?Mike P Wattjes, Anke Vennegoor, Jop Mostert, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 3, 1996
[Problems in weaning from artificial ventilation: 'motor neuron disease']B W van Oosten, E C van Gorp, D P Brandjes, et al.
Methods (San Diego, Calif.)|April 3, 2012
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseasesArjan Malekzadeh, Vincent de Groot, Heleen Beckerman, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|April 26, 2013
PML in a patient treated with dimethyl fumarate from a compounding pharmacyBob W van Oosten, Joep Killestein, Frederik Barkhof, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 15, 2024
[Treatment of multiple sclerosis]Nandi Meijs, Brigit A De Jong, Bob W Van Oosten, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonistB W van Oosten, J Killestein, E M H Mathus-Vliegen, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 16, 2008
[Diabetes and Ramadan]M Ahdi, F Malki, W van Oosten, et al.
Multiple Sclerosis and Related Disorders|November 4, 2019
Patients' expectations of autologous hematopoietic stem cell transplantation as a treatment for MSFloriaan G C M De Kleermaeker, Bernard M J Uitdehaag, Bob W van Oosten
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2007
[Immunomodulatory therapy in multiple sclerosis]B M J Uitdehaag, B Jelles, J Killestein, et al.
Multiple Sclerosis and Related Disorders|October 23, 2017
Neuromyelitis optica spectrum disorder mimicking multiple sclerosisLucas C van Rooij, Mike P Wattjes, Brigit A de Jong, et al.
Journal of Neurology|April 8, 2014
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?Mike P Wattjes, Anke Vennegoor, Jop Mostert, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 3, 1996
[Problems in weaning from artificial ventilation: 'motor neuron disease']B W van Oosten, E C van Gorp, D P Brandjes, et al.
Methods (San Diego, Calif.)|April 3, 2012
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseasesArjan Malekzadeh, Vincent de Groot, Heleen Beckerman, et al.
Pageof 8